| EPB184 | Injection site reaction experience in clinical studies of people using lenacapavir for HIV treatment | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB185 | Preference for long acting injectable (LAI) antiretrovirals for HIV treatment or PrEP in Argentina | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB186 | Early implementation and clinical outcomes of long-acting injectable cabotegravir and rilpivirine in a safety-net HIV clinic | E-poster | Long-acting agents and other drug delivery systems (e.g., injectables, implants, dual therapies, microneedle patches) |
| EPB187 | Viral load suppression after intensive adherence counselling among HIV infected adults at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis | E-poster | Adherence |
| EPB188 | Antiretroviral Therapy (ART) use among pregnant enrollees receiving medicaid managed care | E-poster | Adherence |
| EPB189 | Construction and validation of a questionnaire to measure adverse effects of antiretrovirals in the Mexican population | E-poster | Adherence |
| EPB190 | Do ART and chemsex drugs get along? Potential drug-drug interactions in a cohort of HIV-positive chemsex users | E-poster | Sex-specific (including cis- and transgender) issues of ART efficacy, adverse reactions and complications |
| EPB191 | Periconceptional dolutegravir use and risk of adverse pregnancy outcomes in Kenya | E-poster | Sex-specific (including cis- and transgender) issues of ART efficacy, adverse reactions and complications |
| EPB192 | Impact of mother mentors' model to improve retention in PMTCT services in health facilities supported by Global Funds. a case from Christian Social Services Commission (CSSC)-AMREF, Tanzania | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
| EPB193 | Associations between HIV/ART exposure during pregnancy and adverse maternal and infant outcomes in the MANGO cohort in western Kenya | E-poster | Pregnancy (clinical management issues and pharmacokinetics) and contraception |